An approach that’s bold
An approach that’s bold
An approach that’s bold
Driven by hope
Driven by hope
Driven by hope
Dedication that’s real
Dedication that’s real
Dedication that’s real

Innovative therapeutics that target
serious viral and liver diseases

Assembly Bio is applying our passion, scientific ingenuity and deep knowledge of virology and liver diseases to pursue novel therapies with the potential to change the paradigm for the treatment of serious diseases. Our ambitious and compassionate work has the potential to change lives.

Discover our pipeline
Scientific woman

Our two clinical candidates

for recurrent genital herpes are designed to address the serious consequences of this disease and provide significant innovation over current standard of care.

Learn more
rotating circle rotating circle

Our clinical candidates for chronic hepatitis D, cholestatic liver diseases, and chronic hepatitis B

aim to improve outcomes for individuals facing the significant burden associated with these chronic diseases.

Explore our programs

Passionate. Purpose driven. Patient focused.

Explore opportunities to join our team. We are collectively inspired by and committed to developing novel therapies that improve the lives of people facing serious viral and liver diseases.

Join us!
three scientific people
In the News
September 10, 2026
Assembly Biosciences to Present at the H.C. Wainwright & Co. 28th Annual Global Investment Conference
September 08, 2026
Assembly Biosciences Exercises U.S. Profit-Share Option with Gilead for HSV Helicase-Primase Inhibitor Program
August 13, 2026
Assembly Biosciences Reports Second Quarter 2026 Financial Results and Recent Updates
    rotating circle rotating circle